Analysis of Decompressive Craniectomies with Subsequent Cranioplasties in the Presence of Collagen Matrix Dural Substitute and Polytetrafluoroethylene as an Adhesion Preventative Material

Incidence of Postoperative Hematomas Requiring Surgical Treatment in Neurosurgery: A Retrospective Observational Study

“…[38][39][40][41][42] The relatively high incidence of POH (3.6%) after cranioplasty in this series is also in line with the rates from the literature; POH as a complication occurs after up to 6.9% of cranioplasties. [43][44][45][46][47][48][49] Regarding bypass surgery, it has also been reported previously that ICH after vascular reconstruction surgery (as a result of moyamoya disease) occurs in 2.8% of cases, 50 which is comparable to the detected rate of 1.7% in our series.…”

Risk factors for the development of seizures after cranioplasty in patients that sustained traumatic brain injury: A systematic review

“…Two studies reported only an age range of their patients, overall age 16-71 (177 patients) 24; 27 . One study reported age in its whole cohort of cranioplasty patients but did not report that of its TBI subgroup 18 .…”

Research and application progress on dural substitutes

“…The former is represented by expanded polytetrafluoroethylene and polyurethane dural substitute, and the latter is composed of PGA, copolymer of L-lactic acid and epsilon-caprolactone, or copolymer of lactide and polydioxanone. Absorbable materials are difficult to degrade in vivo, which can lead to foreign body reactions, friction with the cerebral cortex or spinal cord, and other postoperative complications, and the advent of absorbable materials to a certain extent results in the deficiencies above [35][36][37]. Polymers are stretched into filaments by electrospinning, and a three-dimensional structure similar to the natural dural structure is formed.…”